Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

alprostadil

The naturally occuring prostaglandin E1 (PGE1) which displays a variety of pharmacologic actions. Alprostadil is a potent vasodilator agent that increases peripheral blood flow, inhibits platelet aggregation, and induces bronchodilation. Used in the treatment of erectile dysfunction, this agent produces corporal smooth muscle relaxation by binding to PGE receptors, resulting in the activation of adenylate cyclase and the subsequent accumulation of 3'5'-cAMP.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	prostaglandin E1
US brand name:	Caverject MUSE
Abbreviation:	PGE1
Chemical structure:	(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid

alprostadil

Search NCI's Drug Dictionary